Organigram Global (STU:0OG) Short-Term Debt: €0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0OG Organigram Global Inc STU:0OG
60 GF Score
Price €0.81
GF Value €1.55
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Organigram Global Short-Term Debt?

Organigram Global STU:0OG +0.74% 60 Short-Term Debt is €0.0 Mil as of Mar. 2026. GuruFocus rates STU:0OG with a GF Score™ of 60/100 and a GF Value™ of €1.55 (Possible Value Trap). The stock has 1 warning sign investors should review.

Organigram Global's Short-Term Debt for the quarter that ended in Mar. 2026 was €0.0 Mil.

Organigram Global's quarterly Short-Term Debt declined from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€0.0 Mil) and declined from Dec. 2025 (€0.0 Mil) to Mar. 2026 (€0.0 Mil).

Organigram Global's annual Short-Term Debt declined from Aug. 2022 (€0.1 Mil) to Sep. 2024 (€0.0 Mil) and declined from Sep. 2024 (€0.0 Mil) to Sep. 2025 (€0.0 Mil).

Organigram Global Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Organigram Global Short-Term Debt Related Terms

Organigram Global Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Organigram Global's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organigram Global Short-Term Debt Chart

Organigram Global Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24 Sep25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.41 0.05 0.06 0.04 0.02

Organigram Global Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.03 0.02 0.01 0.00
STU:0OG
60GF Score
Organigram Global Inc STU:0OG
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €0.0 Mil mean?
Organigram Global (STU:0OG) has a Short-Term Debt of €0.0 Mil as of Mar. 2026.
Is Organigram Global's Short-Term Debt too high?
Organigram Global's current Short-Term Debt is €0.0 Mil. Overall, Organigram Global has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organigram Global's Short-Term Debt compare to ZTS and UTHR?
Organigram Global's Short-Term Debt of €0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Organigram Global's current Short-Term Debt is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organigram Global stock overvalued right now?
Based on GuruFocus' analysis, Organigram Global (STU:0OG) is currently considered Possible Value Trap. The stock's GF Value™ is €1.55, compared to a current price of €0.81 — trading 47.5% below its estimated fair value. The current Short-Term Debt is €0.0 Mil. Organigram Global's overall GF Score™ is 60/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Organigram Global (STU:0OG), the current Short-Term Debt is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organigram Global (STU:0OG) Overvalued in 2026?

Based on GuruFocus' analysis, Organigram Global stock appears to be undervalued. The current stock price of €0.81 is trading 47.5% below its estimated GF Value™ of €1.55. GuruFocus considers Organigram Global to be Possible Value Trap.

Key valuation signals for STU:0OG:

  • Short-Term Debt: €0.0 Mil
  • GF Value™: €1.55 vs. price of €0.81 (47.5% below fair value)
  • GF Score™: 60/100 with 1 warning sign

No single metric tells the full story. See the STU:0OG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Organigram Global Business Description

Other Exchanges OGI:USAOGI:Canada
Address 145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
60GF Score

Get the complete analysis for STU:0OG

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.81
Price
€1.55
GF Value